Home›Companies›Biotech & Pharma›Nanomind

Nanomind, Inc.

Uses AI models to design single-domain antibodies.

Updated Nov 10, 2026·Latest SEC filing Jun 22, 2026·Suggest an edit

About Nanomind

Nanomind is a private company based in Stamford, Connecticut, incorporated in 2026 in Delaware. It has reported $2,000,000 raised in one offering on Form D since June 2026. Its chief executive is Andres Torrubia.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 1, 2026Jun 22, 2026$2,000,000of $3.0M target8$250KOptions, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nanomind's Form D filed Jun 22, 2026.

AB
Aurelia Bustos
Executive officer and director
AT

Sources

  1. SECNanomind, Inc. filing history